PUBLISHER: KBV Research | PRODUCT CODE: 1335555
PUBLISHER: KBV Research | PRODUCT CODE: 1335555
LAMEA Digital Dose Inhaler Market Size, Share & Industry Trends Analysis Report By Product (Metered Dose Inhaler (MDI), and Dry Powder Inhaler (DPI)), By Type, By Indication (COPD, Asthma, and Others), By Country and Growth Forecast, 2023 - 2030
The Latin America, Middle East and Africa Digital Dose Inhaler Market would witness market growth of 23.2% CAGR during the forecast period (2023-2030).
Inhalers also go by the name's allergy spray and pump. Inhalers are typically used to treat and administer medication for respiratory diseases, such as chronic obstructive pulmonary disease and asthma. Patients with obstructive airway disease (OAD) rely heavily on inhalers for treatment. Inhalers reduce the amount of medication in the pharynx or mouth and the need for precise synchronization with device activation. The digital inhaler is a self-administered device that delivers a specific dose of medication to the airways as a brief burst of aerosolized medication. According to the release and dosage management, the digital inhaler has sensors that detect usage and measure inspiratory flow. Metered dose inhalers (MDI) and dry powder inhalers (DPI) are two of the digital dose inhaler varieties available on the market.
The increase in the incidence of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD), obstructive sleep apnea (OSA), asthma, and respiratory allergies, among others, and a growing mortality rate because of the respective diseases and disorders are among the main drivers promoting the market. Inhalation therapy devices such as metered dose inhalers with internet connectivity, e-dose counters, and compact inhalers, among others, are among the inhalation therapy devices whose technological advancements are accelerating market growth.
Asthma is among the Department of Health's (DoH) main public health priorities. The Asthma program of the Department of Health aims to reduce emergency department visits, hospitalizations, work and school absences, and, most importantly, asthma-related fatalities. This can be accomplished by improving asthma treatment and diagnosis in primary care settings. The government's guidelines aim to enhance the diagnosis and management of adult asthma by primary care physicians, thereby preventing asthma-related premature fatalities. The increasing prevalence of asthma and the continued research into its treatment will increase the use of digital dosage inhalers. Consequently, it is anticipated that the market will expand in the region.
The Brazil market dominated the LAMEA Digital Dose Inhaler Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $821 million by 2030. The Argentina market is showcasing a CAGR of 23.9% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 22.9% during (2023 - 2030).
Based on Product, the market is segmented into Metered Dose Inhaler (MDI), and Dry Powder Inhaler (DPI). Based on Type, the market is segmented into Branded Medication, and Generic Medication. Based on Indication, the market is segmented into COPD, Asthma, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sensirion AG, Teva Pharmaceuticals Industries Ltd., OPKO Health, Inc., Propeller Health (ResMed, Inc.), Novartis AG, AstraZeneca PLC, Glenmark Pharmaceuticals Limited, Beximco Pharmaceuticals Ltd., GlaxoSmithKline PLC and Mundipharma Deutschland GmbH & Co. KG.
Scope of the Study
Market Segments covered in the Report:
By Product
- Metered Dose Inhaler (MDI)
- Dry Powder Inhaler (DPI)
By Type
- Branded Medication
- Generic Medication
By Indication
- COPD
- Asthma
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Sensirion AG
- Teva Pharmaceuticals Industries Ltd.
- OPKO Health, Inc.
- Propeller Health (ResMed, Inc.)
- Novartis AG
- AstraZeneca PLC
- Glenmark Pharmaceuticals Limited
- Beximco Pharmaceuticals Ltd.
- GlaxoSmithKline PLC
- Mundipharma Deutschland GmbH & Co. KG
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA Digital Dose Inhaler Market, by Product
- 1.4.2 LAMEA Digital Dose Inhaler Market, by Type
- 1.4.3 LAMEA Digital Dose Inhaler Market, by Indication
- 1.4.4 LAMEA Digital Dose Inhaler Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter's Five Force Analysis
Chapter 4. Strategies Deployed in Digital Dose Inhaler Market
Chapter 5. LAMEA Digital Dose Inhaler Market by Product
- 5.1 LAMEA Metered Dose Inhaler (MDI) Market by Country
- 5.2 LAMEA Dry Powder Inhaler (DPI) Market by Country
Chapter 6. LAMEA Digital Dose Inhaler Market by Type
- 6.1 LAMEA Branded Medication Market by Country
- 6.2 LAMEA Generic Medication Market by Country
Chapter 7. LAMEA Digital Dose Inhaler Market by Indication
- 7.1 LAMEA COPD Market by Country
- 7.2 LAMEA Asthma Market by Country
- 7.3 LAMEA Others Market by Country
Chapter 8. LAMEA Digital Dose Inhaler Market by Country
- 8.1 Brazil Digital Dose Inhaler Market
- 8.1.1 Brazil Digital Dose Inhaler Market by Product
- 8.1.2 Brazil Digital Dose Inhaler Market by Type
- 8.1.3 Brazil Digital Dose Inhaler Market by Indication
- 8.2 Argentina Digital Dose Inhaler Market
- 8.2.1 Argentina Digital Dose Inhaler Market by Product
- 8.2.2 Argentina Digital Dose Inhaler Market by Type
- 8.2.3 Argentina Digital Dose Inhaler Market by Indication
- 8.3 UAE Digital Dose Inhaler Market
- 8.3.1 UAE Digital Dose Inhaler Market by Product
- 8.3.2 UAE Digital Dose Inhaler Market by Type
- 8.3.3 UAE Digital Dose Inhaler Market by Indication
- 8.4 Saudi Arabia Digital Dose Inhaler Market
- 8.4.1 Saudi Arabia Digital Dose Inhaler Market by Product
- 8.4.2 Saudi Arabia Digital Dose Inhaler Market by Type
- 8.4.3 Saudi Arabia Digital Dose Inhaler Market by Indication
- 8.5 South Africa Digital Dose Inhaler Market
- 8.5.1 South Africa Digital Dose Inhaler Market by Product
- 8.5.2 South Africa Digital Dose Inhaler Market by Type
- 8.5.3 South Africa Digital Dose Inhaler Market by Indication
- 8.6 Nigeria Digital Dose Inhaler Market
- 8.6.1 Nigeria Digital Dose Inhaler Market by Product
- 8.6.2 Nigeria Digital Dose Inhaler Market by Type
- 8.6.3 Nigeria Digital Dose Inhaler Market by Indication
- 8.7 Rest of LAMEA Digital Dose Inhaler Market
- 8.7.1 Rest of LAMEA Digital Dose Inhaler Market by Product
- 8.7.2 Rest of LAMEA Digital Dose Inhaler Market by Type
- 8.7.3 Rest of LAMEA Digital Dose Inhaler Market by Indication
Chapter 9. Company Profiles
- 9.1 Sensirion AG
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Regional Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 SWOT Analysis
- 9.2 Teva Pharmaceutical Industries Ltd.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Regional Analysis
- 9.2.4 Research & Development Expenses
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Partnerships, Collaborations, and Agreements:
- 9.2.5.2 Product Launches and Product Expansions:
- 9.2.6 SWOT Analysis
- 9.3 OPKO Health, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expenses
- 9.3.5 SWOT Analysis
- 9.4 Propeller Health (ResMed, Inc.)
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expenses
- 9.4.5 Recent strategies and developments:
- 9.4.5.1 Partnerships, Collaborations, and Agreements:
- 9.4.6 SWOT Analysis
- 9.5 Novartis AG
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Approvals and Trials:
- 9.5.6 SWOT Analysis
- 9.6 AstraZeneca PLC
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 Recent strategies and developments:
- 9.6.5.1 Approvals and Trials:
- 9.6.6 SWOT Analysis
- 9.7 Glenmark Pharmaceuticals Limited
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 Recent strategies and developments:
- 9.7.5.1 Product Launches and Product Expansions:
- 9.7.6 SWOT Analysis
- 9.8 Beximco Pharmaceuticals Ltd.
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Research & Development Expenses
- 9.8.4 SWOT Analysis
- 9.9 GlaxoSmithKline PLC (GSK)
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 Recent strategies and developments:
- 9.9.5.1 Product Launches and Product Expansions:
- 9.9.6 SWOT Analysis
- 9.10. Mundipharma Deutschland GmbH & Co. KG
- 9.10.1 Company Overview
- 9.10.2 SWOT Analysis
LIST OF TABLES
- TABLE 1 LAMEA Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 2 LAMEA Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 3 LAMEA Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 4 LAMEA Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 5 LAMEA Metered Dose Inhaler (MDI) Market by Country, 2019 - 2022, USD Million
- TABLE 6 LAMEA Metered Dose Inhaler (MDI) Market by Country, 2023 - 2030, USD Million
- TABLE 7 LAMEA Dry Powder Inhaler (DPI) Market by Country, 2019 - 2022, USD Million
- TABLE 8 LAMEA Dry Powder Inhaler (DPI) Market by Country, 2023 - 2030, USD Million
- TABLE 9 LAMEA Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 10 LAMEA Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 11 LAMEA Branded Medication Market by Country, 2019 - 2022, USD Million
- TABLE 12 LAMEA Branded Medication Market by Country, 2023 - 2030, USD Million
- TABLE 13 LAMEA Generic Medication Market by Country, 2019 - 2022, USD Million
- TABLE 14 LAMEA Generic Medication Market by Country, 2023 - 2030, USD Million
- TABLE 15 LAMEA Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 16 LAMEA Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 17 LAMEA COPD Market by Country, 2019 - 2022, USD Million
- TABLE 18 LAMEA COPD Market by Country, 2023 - 2030, USD Million
- TABLE 19 LAMEA Asthma Market by Country, 2019 - 2022, USD Million
- TABLE 20 LAMEA Asthma Market by Country, 2023 - 2030, USD Million
- TABLE 21 LAMEA Others Market by Country, 2019 - 2022, USD Million
- TABLE 22 LAMEA Others Market by Country, 2023 - 2030, USD Million
- TABLE 23 LAMEA Digital Dose Inhaler Market by Country, 2019 - 2022, USD Million
- TABLE 24 LAMEA Digital Dose Inhaler Market by Country, 2023 - 2030, USD Million
- TABLE 25 Brazil Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 26 Brazil Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 27 Brazil Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 28 Brazil Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 29 Brazil Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 30 Brazil Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 31 Brazil Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 32 Brazil Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 33 Argentina Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 34 Argentina Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 35 Argentina Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 36 Argentina Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 37 Argentina Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 38 Argentina Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 39 Argentina Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 40 Argentina Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 41 UAE Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 42 UAE Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 43 UAE Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 44 UAE Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 45 UAE Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 46 UAE Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 47 UAE Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 48 UAE Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 49 Saudi Arabia Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 50 Saudi Arabia Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 51 Saudi Arabia Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 52 Saudi Arabia Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 53 Saudi Arabia Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 54 Saudi Arabia Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 55 Saudi Arabia Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 56 Saudi Arabia Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 57 South Africa Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 58 South Africa Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 59 South Africa Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 60 South Africa Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 61 South Africa Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 62 South Africa Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 63 South Africa Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 64 South Africa Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 65 Nigeria Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 66 Nigeria Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 67 Nigeria Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 68 Nigeria Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 69 Nigeria Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 70 Nigeria Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 71 Nigeria Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 72 Nigeria Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 73 Rest of LAMEA Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 74 Rest of LAMEA Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 75 Rest of LAMEA Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 76 Rest of LAMEA Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 77 Rest of LAMEA Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 78 Rest of LAMEA Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 79 Rest of LAMEA Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 80 Rest of LAMEA Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 81 Key Information - Sensirion AG
- TABLE 82 Key Information - Teva Pharmaceuticals Industries Ltd.
- TABLE 83 Key Information - OPKO Health, Inc.
- TABLE 84 Key Information - Propeller Health
- TABLE 85 Key Information - Novartis AG
- TABLE 86 KEY INFORMATION - AstraZeneca PLC
- TABLE 87 Key Information - Glenmark Pharmaceuticals Limited
- TABLE 88 Key Information - Beximco Pharmaceuticals Ltd.
- TABLE 89 Key Information - GlaxoSmithKline PLC
- TABLE 90 Key Information - Mundipharma Deutschland GmbH & Co. KG
List of Figures
- FIG 1 Methodology for the research
- FIG 2 LAMEA Digital Dose Inhaler Market, 2019 - 2030, USD Million
- FIG 3 Key Impacting Factors digital dose inhaler market
- FIG 4 Porter's Five Force Analysis: Digital Dose Inhaler Market
- FIG 5 LAMEA Digital Dose Inhaler Market share by Product, 2022
- FIG 6 LAMEA Digital Dose Inhaler Market share by Product, 2030
- FIG 7 LAMEA Digital Dose Inhaler Market by Product, 2019 - 2030, USD Million
- FIG 8 LAMEA Digital Dose Inhaler Market share by Type, 2022
- FIG 9 LAMEA Digital Dose Inhaler Market share by Type, 2030
- FIG 10 LAMEA Digital Dose Inhaler Market by Type, 2019 - 2030, USD Million
- FIG 11 LAMEA Digital Dose Inhaler Market share by Indication, 2022
- FIG 12 LAMEA Digital Dose Inhaler Market share by Indication, 2030
- FIG 13 LAMEA Digital Dose Inhaler Market by Indication, 2019 - 2030, USD Million
- FIG 14 LAMEA Digital Dose Inhaler Market share by Country, 2022
- FIG 15 LAMEA Digital Dose Inhaler Market share by Country, 2030
- FIG 16 LAMEA Digital Dose Inhaler Market by Country, 2019 - 2030, USD Million
- FIG 17 SWOT Analysis: SENSIRION AG
- FIG 18 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
- FIG 19 SWOT Analysis: Teva Pharmaceuticals Industries Ltd.
- FIG 20 SWOT Analysis: OPKO Health, Inc.
- FIG 21 SWOT Analysis: Propeller Health
- FIG 22 SWOT Analysis: Novartis AG
- FIG 23 SWOT Analysis: AstraZeneca PLC
- FIG 24 SWOT Analysis: Glenmark Pharmaceuticals Ltd.
- FIG 25 SWOT Analysis: Beximco Pharmaceuticals Ltd.
- FIG 26 SWOT Analysis: GlaxoSmithKline PLC
- FIG 27 SWOT Analysis: Mundipharma Deutschland GmbH & Co. KG
